A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers
Crossref DOI link: https://doi.org/10.1007/s12029-017-0028-5
Published Online: 2017-11-16
Published Print: 2019-03-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Ying http://orcid.org/0000-0001-8087-459X
Camateros, Pierre
Cheung, Winson Y.
Text and Data Mining valid from 2017-11-16
Version of Record valid from 2017-11-16
Article History
First Online: 16 November 2017
Compliance with Ethical Standards
: Ethics approval was obtained from the Institutional Review Board prior to the conduct of the study.
: The authors declare that they have no conflict of interest.